Publikationen, an denen er mitarbeitet Miguel Angel Barajas Vélez (12)

2007

  1. Multipotent Adult Progenitor Cells (MAPC) contribute to hepatocarcinoma neovasculature

    Biochemical and Biophysical Research Communications, Vol. 364, Núm. 1, pp. 92-99

2006

  1. Intrahepatic injection of adenovirus reduces inflammation and increases gene transfer and therapeutic effect in mice

    Hepatology, Vol. 44, Núm. 3, pp. 623-632

2004

  1. Treatment of colorectal and hepatocellular carcinomas by adenoviral mediated gene transfer of endostatin and angiostatin-like molecule in mice

    Gut, Vol. 53, Núm. 4, pp. 561-567

2003

  1. In vitro and in vivo comparative study of chimeric liver-specific promoters

    Molecular Therapy, Vol. 7, Núm. 3, pp. 375-385

  2. Pancreatic cancer escape variants that evade immunogene therapy through loss of sensitivity to IFNγ-induced apoptosis

    Gene Therapy, Vol. 10, Núm. 13, pp. 1067-1078

2002

  1. A novel strategy for the generation of angiostatic kringle regions from a precursor derived from plasminogen

    Gene Therapy, Vol. 9, Núm. 23, pp. 1600-1606

2001

  1. Adenovirus-mediated CD40 ligand gene therapy in a rat model of orthotopic hepatocellular carcinoma

    Hepatology, Vol. 34, Núm. 1, pp. 72-81

  2. Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin 12

    Hepatology, Vol. 33, Núm. 1, pp. 52-61

  3. Gene therapy of primary and metastatic liver tumors.

    Medical science monitor : international medical journal of experimental and clinical research, Vol. 7 Suppl 1, pp. 76-77

2000

  1. Adenoviral gene transfer of interleukin 12 into tumors synergizes with adoptive T cell therapy both at the induction and effector level

    Human Gene Therapy, Vol. 11, Núm. 1, pp. 113-125

  2. Intratumoral coinjection of two adenoviruses, one encoding the chemokine IFN-γ-inducible protein-10 and another encoding IL-12, results in marked antitumoral synergy

    Journal of Immunology, Vol. 164, Núm. 6, pp. 3112-3122

  3. Transduction of hepatocellular carcinoma (HCC) using recombinant adeno- associated virus (rAAV): In vitro and in vivo effects of genotoxic agents

    Journal of Hepatology, Vol. 32, Núm. 6, pp. 975-985